Pulmonary Hypertension 2021
DOI: 10.1183/13993003.congress-2021.pa1931
|View full text |Cite
|
Sign up to set email alerts
|

Biological quality control and core laboratory considerations for CPET in a clinical trial of ralinepag in patients with pulmonary arterial hypertension: ADVANCE CAPACITY

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles